全植入式主动中耳植入物:大样本听力与安全性结果
该回顾性病例综述纳入172耳(166例)感音神经性听力损失患者,评估全植入式主动中耳植入物的听力性能与安全性。植入物在多数测试类别中较未助听及患者自用助听器提供显著听力获益,骨导阈值未受影响,最常见不良事件为味觉障碍(39.1%),部分患者耳鸣完全缓解。
要点
- 植入物较未助听在至6 kHz各频率均有显著增益。
- 植入物在1500和2000 Hz增益及SRT、WRS50均显著优于助听器。
- 骨导阈值未受影响,味觉障碍最常见(39.1%)。
核心结论
- 植入物在多数测试类别中较未助听和患者自用助听器提供显著听力获益,不良事件轻微。
- 部分患者植入后耳鸣完全缓解。
研究设计与样本
- 回顾性病例综述,纳入172耳(166例)感音神经性听力损失患者接受全植入式主动中耳植入物。
- 平均随访35.7个月。
主要发现
- 植入物较未助听在至6 kHz各频率提供显著增益。
- 植入物在1500和2000 Hz的增益显著优于基线助听(P ≤ .001)。
- 植入物SRT显著优于基线助听(29.9 dB vs. 38.5 dB,P ≤ .001)。
- 50 dB呈现级下植入物WRS显著优于基线助听(65.6% vs. 45.5%,P ≤ .001)。
- 骨导阈值未受植入物影响。
关键数值与推荐
- 最常见不良事件为味觉障碍,发生率39.1%。
- 植入前有耳鸣者中56.1%耳鸣缓解。
- 15.7%需修正手术,4%最终取出植入物。
临床怎么用
- 对于感音神经性听力损失患者,全植入式主动中耳植入物可作为一种助听选项,在部分频率和言语识别上可能优于传统助听器。
- 需告知患者味觉障碍、修正手术及取出植入物的风险,并关注耳鸣改善可能。
局限性
- 回顾性设计,证据等级为4。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate hearing performance and safety measures in a large group of totally implantable active middle ear implant (AMEI) wearers. METHODS: Retrospective case review of 172 ears (166 patients) with sensorineural hearing loss undergoing implantation of a totally implantable AMEI. Pure-tone air and bone thresholds, pure-tone average, speech reception threshold (SRT), and word recognition scores (WRS) at phonetically balanced maximum and at 50 dB (WRS50) were assessed at baseline unaided, with a hearing aid (baseline aided [BLA]), with the implant at activation, and for best implant postoperative measurement. Adverse events were reviewed. RESULTS: Mean length of follow-up was 35.7 months. Compared to unaided, the implant provided significant gain at all frequencies through 6 kHz. Amount of gain was significantly better with the implant than BLA at 1,500 and 2,000 Hz (P ≤ .001). Implant SRT was also significantly improved compared to BLA (29.9 dB vs. 38.5 dB, P ≤ .001). At a 50-dB presentation level, WRS was significantly better with the implant than BLA (65.6% vs. 45.5%, P ≤ .001). Bone conduction thresholds were not affected by the implant. The most common adverse event was taste disturbance, which occurred in 39.1%. In subjects with preimplant tinnitus, 56.1% experienced resolution of their tinnitus. Revision surgery was required in 15.7%, and 4% were ultimately explanted. CONCLUSION: The implant provided significant hearing benefit compared to unaided and to the subjects' own hearing aids in most test categories, with minimal adverse events. Many subjects experienced complete resolution of their tinnitus after implantation. LEVEL OF EVIDENCE: 4 Laryngoscope, 128:2872-2878, 2018.
引用
- Shohet JA, Gende DM, Tanita CS, et al. Totally implantable active middle ear implant: Hearing and safety results in a large series. Laryngoscope. 2018. PMID: 30194720. doi:10.1002/lary.27246
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。